BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38518061)

  • 1. Pancreatic Cysts Greater Than 1 cm Are Associated With an Increased Risk for Developing Pancreatic Cancer in Individuals From Pancreatic-Cancer Prone Kindreds Undergoing Surveillance.
    Aijazi M; Fasanella KE; McGrath K; Smith LM; Singhi AD; Brand RE
    Pancreas; 2024 Apr; 53(4):e350-e356. PubMed ID: 38518061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
    Munigala S; Javia SB; Agarwal B
    Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
    Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
    Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic ductal adenocarcinoma with intratumoral cystic lesions on MRI: correlation with histopathological findings.
    Yoon SE; Byun JH; Kim KA; Kim HJ; Lee SS; Jang SJ; Jang YJ; Lee MG
    Br J Radiol; 2010 Apr; 83(988):318-26. PubMed ID: 19620175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
    Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
    Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
    Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
    AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.
    Konings IC; Harinck F; Poley JW; Aalfs CM; van Rens A; Krak NC; Wagner A; Nio CY; Sijmons RH; van Dullemen HM; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ;
    Pancreas; 2017 Jan; 46(1):28-34. PubMed ID: 27846136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance of EUS and MRI/MRCP findings among high-risk individuals undergoing pancreatic cancer screening.
    Siegel A; Friedman M; Feldman D; Krishnan K; Casey B; Pisuchpen N; Kambadakone A; Chung DC
    Pancreatology; 2022 Nov; 22(7):951-958. PubMed ID: 35995658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoepithelial cysts of the pancreas. Can preoperative imaging distinguish this benign lesion from malignant or pre-malignant cystic pancreatic lesions?
    Kavuturu S; Sarwani NE; Ruggeiro FM; Deshaies I; Kimchi ET; Kaifi JT; Staveley-O'Carroll KF; Gusani NJ
    JOP; 2013 May; 14(3):250-5. PubMed ID: 23669473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental, Small (< 3 cm), Unilocular, Pancreatic Cysts: Factors That Predict Lesion Progression during Imaging Surveillance.
    Kim GE; Shin SS; Kim JW; Heo SH; Lim HS; Jun CH; Jeong YY
    Korean J Radiol; 2017; 18(6):915-925. PubMed ID: 29089824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large Duct Pancreatic Ductal Adenocarcinoma: A Morphological Variant of Pancreatic Ductal Adenocarcinoma With Distinct CT and MRI Characteristics.
    Choi SJ; Kim SJ; Kim DW; Lee SS; Hong SM; Kim KW; Kim JH; Kim HJ; Byun JH
    Korean J Radiol; 2023 Dec; 24(12):1232-1240. PubMed ID: 38016682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
    Canto MI; Hruban RH; Fishman EK; Kamel IR; Schulick R; Zhang Z; Topazian M; Takahashi N; Fletcher J; Petersen G; Klein AP; Axilbund J; Griffin C; Syngal S; Saltzman JR; Mortele KJ; Lee J; Tamm E; Vikram R; Bhosale P; Margolis D; Farrell J; Goggins M;
    Gastroenterology; 2012 Apr; 142(4):796-804; quiz e14-5. PubMed ID: 22245846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals.
    Overbeek KA; Goggins MG; Dbouk M; Levink IJM; Koopmann BDM; Chuidian M; Konings ICAW; Paiella S; Earl J; Fockens P; Gress TM; Ausems MGEM; Poley JW; Thosani NC; Half E; Lachter J; Stoffel EM; Kwon RS; Stoita A; Kastrinos F; Lucas AL; Syngal S; Brand RE; Chak A; Carrato A; Vleggaar FP; Bartsch DK; van Hooft JE; Cahen DL; Canto MI; Bruno MJ;
    Gastroenterology; 2022 Mar; 162(3):772-785.e4. PubMed ID: 34678218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis.
    Muraki T; Jang KT; Reid MD; Pehlivanoglu B; Memis B; Basturk O; Mittal P; Kooby D; Maithel SK; Sarmiento JM; Christians K; Tsai S; Evans D; Adsay V
    Mod Pathol; 2022 Jan; 35(1):96-105. PubMed ID: 34518632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated hemoglobin A1c is associated with the presence of pancreatic cysts in a high-risk pancreatic surveillance program.
    Bar-Mashiah A; Aronson A; Naparst M; DiMaio CJ; Lucas AL
    BMC Gastroenterol; 2020 May; 20(1):161. PubMed ID: 32460749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cysts: What imaging characteristics are associated with development of pancreatic ductal adenocarcinoma?
    Paroder V; Flusberg M; Kobi M; Rozenblit AM; Chernyak V
    Eur J Radiol; 2016 Sep; 85(9):1622-6. PubMed ID: 27501898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyst Fluid Telomerase Activity Predicts the Histologic Grade of Cystic Neoplasms of the Pancreas.
    Hata T; Dal Molin M; Suenaga M; Yu J; Pittman M; Weiss M; Canto MI; Wolfgang C; Lennon AM; Hruban RH; Goggins M
    Clin Cancer Res; 2016 Oct; 22(20):5141-5151. PubMed ID: 27230749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for pancreatic cancer in high-risk individuals.
    Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
    BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.